Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 11/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | DRD5 | P21918 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.35 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL204451 | 0.85 | LPL (0.46) | LPLLIPGROCK1BACE1F11 | |
| SCHEMBL30079660 | 0.84 | LPL (0.47) | LPLLIPGROCK1BACE1MAOA | |
| SCHEMBL18164696 | 0.84 | LPL (0.47) | LPLLIPGROCK1BACE1PRMT5 | |
| SCHEMBL29265 | 0.84 | LPL (0.47) | LPLLIPGROCK1BACE1MAOA | |
| SCHEMBL29984001 | 0.81 | MAOB (0.47) | LPLLIPGCYP2A6MAOAMAOB | |
| SCHEMBL27080470 | 0.81 | MAOB (0.47) | LPLLIPGCYP2A6MAOAMAOB | |
| SCHEMBL15912518 | 0.81 | LIPG (0.47) | LPLLIPGROCK1F11P2RX7 | |
| SCHEMBL5781980 | 0.80 | LPL (0.46) | LPLLIPGBACE1F11P2RX7 | |
| SCHEMBL30860136 | 0.78 | LIPG (0.46) | LPLLIPGROCK1BACE1F11 | |
| SCHEMBL202622 | 0.78 | LIPG (0.46) | LPLLIPGROCK1BACE1F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253542-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | OR10J3, TRPA1, TRPM4 | LPL 352/4885LIPG 630/4885ROCK1 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.